DR JULIE MAKANI
Julie Makani is a Wellcome Trust Research Fellow and Senior lecturer in Haematology and Blood Transfusion at Muhimbili University of Health and Allied Sciences (MUHAS). Dr Makani trained in Medicine (Tanzania) and Internal Medicine (UK), and completed her PhD in clinical epidemiology of sickle cell disease (SCD). In 2004, she received a Wellcome Trust training fellowship and established the SCD programme at MUHAS, with prospective surveillance of over 2,000 SCD patients. The focus was on malaria, bacterial infections and stroke, considered to significantly contribute to illness and death when interventions are available. Working with colleagues, they have developed a biomedical research and healthcare programme (http://www.muhimbili-wellcome.org/, which is one of the largest SCD cohorts from one centre in the world. Her current interest is in role of anaemia and foetal haemoglobin in influencing disease burden in SCD. She is working with colleagues to establish networks at national (Sickle Cell Foundation of Tanzania); regional [Sickle Cell Disease Research Network of East and Central Africa (REDAC)] and Africa (Sickle CHARTA - Consortium for Health, Advocacy, Research and Training in Africa). At Global level she is on the technical advisory group of Global SCD Research Network (http://www.globalsicklecelldisease.org ), co-chairing the working group responsible for hydroxyurea therapy in Africa.
She is a consultant physician at Muhimbili National Hospital (http://www.mnh.or.tz/) and clinical research fellow in the Nuffield department of clinical medicine, Oxford University . She received the 2011 Royal Society Pfizer Award ((http://www.youtube.com/watch?v=sd17odE1YLs)) for her work in using anaemia in SCD as a model of translating genetic research into health benefit. In 2012 she was elected a Fellow of Tanzania Academy of Sciences and in 2013, Fellow of Royal College of Physicians of United Kingdom.
No comments:
Post a Comment